ANALYSIS OF PHARMACOTHERAPY FOR HYPERTENSION IN TERMS OF OVERALL CARDIOVASCULAR RISK

DOI: https://doi.org/10.29296/25877305-2018-01-06
Download full text PDF
Issue: 
1
Year: 
2018

T. Potupchik (1), Candidate of Medical Sciences; O. Veselova (1), Candidate of Medical Sciences; L. Evert (2), MD; M. Makarova (1), MD; O. Averyanova (3) 1-Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University 2-Research Institute of Medical Problems of the North, Krasnoyarsk Research Center, Siberian Branch, Russian Academy of Sciences 3-Krasnoyarsk Interdistrict Maternity Hospital Four

The paper gives the results of an analysis of pharmacotherapy in patients with hypertension in terms of overall cardiovascular risk factors and their degree.

Keywords: 
cardiology
hypertension
coronary heart disease
cardiovascular risk factors
pharmacotherapy



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Glechjan A.M. Klinicheskaja effektivnost' perindoprila i ego vlijanie na diastolicheskuju funktsiju i remodelirovanie levogo zheludochka, zhestkost' magistral'nyh arterij i endotelij-zavisimuju vazodilatatsiju u patsientov s arterial'noj gipertoniej i serdechnoj nedostatochnost'ju c sohranennoj sistolicheskoj funktsiej levogo zheludochka. Avtoref. dis. ... kand. med. nauk. M., 2012; 27 s
  2. Dralova O.V., Maksimov M.L. Perindopril – vozmozhnosti antigipertenzivnoj i nefroprotektivnoj terapii // Rats. farmakoter. v kardiol. – 2011; 7: 501–6.
  3. Karpov Ju.A., Gorbunov V.M., Deevi A.D. dr. Issledovanie PRORYV 2: vlijanie fiksirovannoj kombinatsii perindopril / amlodipin na arterial'noe davlenie, izmerennoe v kabinete vracha, s pomosch'ju sutochnogo monitorirovanija i samokontrolja, u patsientov s nekontroliruemoj arterial'noj gipertoniej // Novosti kardiologii. – 2014; 1: [Elektronnyj resurs]. URL: http://medi.ru/doc/f422002.htm
  4. Kobalava Zh.D., Kotovskaja Ju.V. Arterial'naja gipertonija v XXI veke: dostizhenija, problemy perspektivy / M., Bionika Media, 2013; 272 s.
  5. Kobalava Zh.D., Kotovskaja Ju.V., Luk'janova E.A. Kombinirovannaja terapija arterial'noj gipertonii fiksirovannoj kombinatsiej perindopril A/amlodipin v real'noj klinicheskoj praktike: organizatsija i osnovnye rezul'taty programmy KONSTANTA // Kardiologija. – 2013; 6: 25–34.
  6. Morozova T.E. Sartany v lechenii bol'nyh arterial'noj gipertenziej vysokogo riska: vozmozhnosti kandesartana // Sistemnye gipertenzii. – 2013; 10 (2): 13–9.
  7. Potupchik T.V., Veselova O.F., Evert L.S. i dr. Bufernye formy atsetilsalitsilovoj kisloty: effektivnost' i bezopasnost' // Vrach. – 2015; 11: 26–30.
  8. Radchenko A.D. Beta-blokatory v lechenii arterial'noj gipertenzii: za i protiv // Arterial'naja gipertenzija. – 2012; 6: 3–10.
  9. Rekomendatsii po lecheniju arterial'noj gipertonii. ESH/ESC 2013 // Ros. kardiol. zhurn. – 2014; 1: 7–94.
  10. Rodionov A.V. Kombinirovannaja farmakoterapija arterial'noj gipertenzii: vzgljad cherez prizmu klinicheskih rekomendatsij 2013 goda // Sistemnye gipertenzii. – 2013; 10 (2): 5–9.
  11. Tkacheva O.N. Runihina N.K., Sharashkina N.V. Torasemid: dopolnitel'nye preimuschestva primenenija pri arterial'noj gipertenzii u zhenschin v postmenopauze // Sistemnye gipertenzii. – 2013; 10 (2): 9–13.
  12. Dahlof B., Sever P., Poulter N. et al. Prevention of cardiovascular events with an attihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo–Scandinavian Cardiac Outcomes Trial–Blood Pressure Lowering Arm (ASCOT–BPLA):
  13. A multicentre randomised controlled trial // Lancet. – 2005; 366: 895–906.